CTNNB1 and malignant colon neoplasm: Beta-catenin serves as an effective anticancer drug target. In vitro selected TCF RNA aptamer binds with T-cell factor and inhibits the tumorigenic function of beta-catenin in colon cancer cells by modulating beta-catenin target genes such as cyclin D1 and matrix metalloproteinase-7 [75].